Literature DB >> 26569194

Clinical Characteristics of Carbapenem-resistant Klebsiella pneumoniae Infections in Ill and Colonized Children in Colombia.

Alejandro Díaz1, Diana Cristina Ortiz, Mónica Trujillo, Carlos Garcés, Fabian Jaimes, Andrea Victoria Restrepo.   

Abstract

BACKGROUND: Multidrug-resistant Gram-negative infections represent a growing problem and a serious global threat. Data in children are scarce. Klebsiella pneumoniae carbapenemases (KPC) are the most common mechanism of resistance this organism has developed. We report the clinical characteristics and outcomes from a cohort of children infected or colonized with carbapenem-resistant K. pneumoniae (CRKp) at a tertiary care center in Medellín, Colombia.
METHODS: We performed a retrospective chart review of all pediatric cases from whom CRKp isolates were obtained from 2008 to 2013. Clinical characteristics and outcomes were recorded.
RESULTS: A total of 34 infected children (median age, 22.8 months) with 43 episodes and 55 colonized patients (median age, 33 months) were identified. All patients had at least 1 risk factor previously related with multidrug-resistant Gram-negative infections (premorbid conditions, previous exposure to antibiotics, prolonged length of stay and use of indwelling devices). Urinary tract infections, abdominal infections and bacteremia were the most common clinical presentations. Overall mortality was 38%, and it was lower when a meropenem-containing regimen was used. Colistin was the most used antibiotic either alone or in combination and was associated with 8.8% of nephrotoxicity.
CONCLUSION: CRKp infections have high mortality in children and usually occur in children with comorbidities, prolonged hospital stay and prior antibiotic exposure. Combined therapy with meropenem-containing regimens seems to be the best option in severely ill children.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26569194     DOI: 10.1097/INF.0000000000000987

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  13 in total

Review 1.  The global epidemiology of carbapenemase-producing Enterobacteriaceae.

Authors:  David van Duin; Yohei Doi
Journal:  Virulence       Date:  2016-08-11       Impact factor: 5.882

Review 2.  Carbapenem-Resistant Gram-Negative Bacterial Infections in Children.

Authors:  David Aguilera-Alonso; Luis Escosa-García; Jesús Saavedra-Lozano; Emilia Cercenado; Fernando Baquero-Artigao
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

Review 3.  Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae.

Authors:  Jesús Rodríguez-Baño; Belén Gutiérrez-Gutiérrez; Isabel Machuca; Alvaro Pascual
Journal:  Clin Microbiol Rev       Date:  2018-02-14       Impact factor: 26.132

4.  Survival of Carbapenem-Resistant Klebsiella pneumoniae Sequence Type 258 in Human Blood.

Authors:  Frank R DeLeo; Scott D Kobayashi; Adeline R Porter; Brett Freedman; David W Dorward; Liang Chen; Barry N Kreiswirth
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

5.  Clinical and Molecular Epidemiologic Characteristics of Ceftazidime/Avibactam-Resistant Carbapenem-Resistant Klebsiella pneumoniae in a Neonatal Intensive Care Unit in China.

Authors:  Juanjuan Zhou; Junwen Yang; Fupin Hu; Kaijie Gao; Jiufeng Sun; Junmei Yang
Journal:  Infect Drug Resist       Date:  2020-07-27       Impact factor: 4.003

6.  Multicenter Study of the Risk Factors for Colonization or Infection with Carbapenem-Resistant Enterobacteriaceae in Children.

Authors:  Kathleen Chiotos; Pranita D Tamma; Kelly B Flett; Matthew Naumann; Manjiree V Karandikar; Warren B Bilker; Theoklis Zaoutis; Jennifer H Han
Journal:  Antimicrob Agents Chemother       Date:  2017-11-22       Impact factor: 5.191

7.  Molecular epidemiology of carbapenem resistant gram-negative bacilli from infected pediatric population in tertiary - care hospitals in Medellín, Colombia: an increasing problem.

Authors:  Johanna M Vanegas; O Lorena Parra; J Natalia Jiménez
Journal:  BMC Infect Dis       Date:  2016-09-01       Impact factor: 3.090

8.  A matched case-control study to assess the carbapenem-resistant Enterobacteriaceae infections among hospitalized children at King Fahad Medical City, Riyadh, Saudi Arabia.

Authors:  Omar A Alzomor; Tariq S Alfawaz; Amani Abu-Shaheen; Mohammed A Alshehri; Dayel Al Shahrani
Journal:  Saudi Med J       Date:  2019-11       Impact factor: 1.484

9.  Clinical and molecular characteristics, risk factors and outcomes of Carbapenem-resistant Klebsiella pneumoniae bloodstream infections in the intensive care unit.

Authors:  Xia Zheng; Jian-Feng Wang; Wang-Lan Xu; Jun Xu; Juan Hu
Journal:  Antimicrob Resist Infect Control       Date:  2017-10-02       Impact factor: 4.887

10.  The role of the bla KPC gene in antimicrobial resistance of Klebsiella pneumoniae.

Authors:  Atossa Ghasemnejad; Monir Doudi; Nour Amirmozafari
Journal:  Iran J Microbiol       Date:  2019-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.